Precision genomics is revolutionizing our comprehension of disease. By analyzing an individual's unique genetic makeup, we can pinpoint potential risks and develop customized treatment plans. This methodology holds immense opportunity for enhancing patient outcomes and progressing healthcare into a new era of specificity. Through genomic examinatio

during the validation phase, we compared the above-described 7 genes by MethLight qPCR approach in Chinese Han males (N = 109 SCZ people, N = ninety nine methamphetamine use condition with MIP sufferers, N = one hundred fifty methamphetamine use disorder with out MIP people, N = 282 ordinary controls, age array: eighteen–fifty man